What to Know about Breakthrough COVID-19 Infections

Translate to Spanish or other 102 languages!

As the Delta variant continues to spread, more breakthrough infections are being reported among those who have been vaccinated for COVID-19. Image for illustration purposes.

Mega Doctor News

- Advertisement -

Cleveland Clinic – As the Delta variant continues to spread, more breakthrough infections are being reported among those who have been vaccinated for COVID-19.

“It’s not too unexpected that we are going to see breakthrough infections because we know that immunity doesn’t last forever,” explained Frank Esper, MD, infectious disease specialist with Cleveland Clinic. “We do this all the time with our influenza vaccine where everybody needs a vaccine every year. We also do it with the tetanus vaccine. Everybody is supposed to get it every five to ten years because your immunity wanes over time.”

Dr. Esper said even though the COVID-19 vaccine isn’t completely full proof, it will help to reduce the severity of symptoms if you were to get sick.

- Advertisement -

In fact, data shows a majority of patients currently hospitalized for the virus are not vaccinated.

He said if you are concerned about breakthrough infections, there are other measures you can take to protect yourself, like routinely washing your hands, wearing a mask and practicing social distancing.

However, the vaccine is considered the best line of defense.

“There’s not one single strategy that will prevent infection with this virus by itself. It’s really going to have to be multiple strategy all working together, at least right now. The best single thing you can do to protect yourself and those around you is to be vaccinated,” he explained.

- Advertisement -

Dr. Esper also notes the more people who get vaccinated, the harder it will be for the virus to mutate and potentially get worse.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.

South Texas Health System Invests $25,000 in VIDA to Expand Healthcare Career Opportunities in the RGV

To help address the ongoing need for qualified workers in the Rio Grande Valley, South Texas Health System (STHS) has renewed its support of Valley Initiative for Development and Advancement (VIDA) through a $25,000 annual grant.
- Advertisement -